Pralmorelin is an orally-active, synthetic peptide drug. It was also under investigation for the treatment of GHD and short stature (pituitary dwarfism). Reference standards of Pralmorelin API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
No Data Found
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
